Skip to main content
Erschienen in: Allergy, Asthma & Clinical Immunology 1/2023

Open Access 01.12.2023 | Short report

“Vegan” and “plant-based” claims: risk implications for milk- and egg-allergic consumers in Canada

verfasst von: Silvia Dominguez, Jérémie Théolier, Kamila Lizée, Beatrice Povolo, Jennifer Gerdts, Samuel B. Godefroy

Erschienen in: Allergy, Asthma & Clinical Immunology | Ausgabe 1/2023

Abstract

The market share of foods carrying labels suggesting absence of animal ingredients has significantly increased in recent years. The purpose of this study was to document the purchasing behaviour of egg- or milk-allergic consumers vis-à-vis food marketed as “vegan” and “plant-based”, and to evaluate the associated allergenic risk. A survey was conducted among egg- and milk-allergic consumers and revealed that 86% (margin of error 5.4%; confidence level 95%) would buy “vegan” products, indicating this label may be perceived as a substitute for “free from milk and eggs”. To assess the risk posed by these products, 87 prepackaged foods with “vegan” and/or “plant-based” claims purchased in Quebec were tested for milk proteins, and 64 for egg proteins. Overall, 5.7% and 0% occurrence of milk and egg proteins, respectively, were observed, suggesting that the analysed prepackaged foods carrying “vegan” and/or “plant-based” labels pose little risk to egg- or milk-allergic consumers. However, this is likely due to allergen management practices applied by the Canadian manufacturers of the products tested, and should not be attributed to the use of “vegan” or similar labels. Enhanced regulatory requirements for the use of these labels, and an education campaign on their meaning with respect to allergy-related risks, are necessary to better inform and protect egg- and milk-allergic consumers.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s13223-023-00836-w.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
PAL
Precautionary allergen labelling
CFIA
Canadian Food Inspection Agency
FAO
Food and Agriculture Organization of the United Nations
WHO
World Health Organization

Introduction

The availability of prepackaged foods marketed as “vegan” has significantly increased in the last decades, reaching a global market value of more than USD 24 billion in 2022 [1]. This growth is expected to continue, driven by consumers’ increasing concerns related to the environment, sustainability, and animal welfare, as well as their interest in foods perceived as healthier [2]. When referring to foods, the term “vegan” generally implies that ingredients of animal origin (meat, poultry, fish, seafood), including eggs and milk, are not part of the formulation [3]. Individuals allergic to animal proteins (e.g., milk, egg) may therefore perceive “vegan” labels as indicators of safety and use them to guide purchasing decisions.
Although “vegan” certifications and standards (ISO 23662:2021) for prepackaged foods exist, they do not guarantee the absence of cross-contact allergens of animal origin. More importantly, this term is generally not specifically defined in food regulations. In Canada, the Canadian Food Inspection Agency (CFIA) allows for some flexibility in its interpretation and notes that “While a vegan diet or foods are made from only plant-based ingredients, it is also recognized that several definitions of ‘vegan’ exist. When making claims on a food, companies can apply additional criteria or standards that take account of other factors in addition to the ingredients of the food” [4]. Subsection 5 (1) of the Food and Drugs Act [5] requires information on food labels to be “truthful and not misleading” and therefore applies to products marketed as “vegan”, but its enforcement in this context is not feasible in the absence of a regulatory definition or standard. Yet, most CFIA recalls of products marketed as “vegan” are due to presence of undeclared ingredients of animal origin (19/21, since 2012), notably milk and egg [6]. Similarly, cases of “vegan” products containing these allergens have been reported in several jurisdictions other than Canada [3, 7, 8], posing a serious risk to allergic consumers, and in one instance, a fatality [9].
In addition, “plant-based” and related food labels are experiencing explosive growth worldwide, with a forecasted market share around USD 34 billion in 2024 [10]. These foods are expected to be made primarily of plant-based ingredients, and are gaining popularity as a viable alternative to animal proteins in terms of cost, nutrition and sustainability. However, foods marketed as “plant-based” may be formulated to comply with diets other than “vegan”, such as “vegetarian” (similar to “vegan” but may include eggs, dairy products or honey), “ovo-lacto-vegetarian” (vegetarian with the inclusion of eggs and dairy) or even “flexitarian” (vegetarian with occasional inclusion of animal products), and thus do not by definition exclude animal ingredients [10]. Some plant-based proteins have been identified as potential novel allergens (e.g., pulses) [11, 12]; yet “plant-based” foods may appeal to consumers allergic to animal proteins [13]. Requirements for specific “plant-based” foods and beverages are considered in Canadian regulations, mainly addressing nutritional value and product naming [14, 15], but provisions related to animal ingredients content are not included.
Thus, the objectives of this study were (i) to report on the buying behaviour of egg- and milk-allergic consumers in Canada related to products containing a “vegan” claim, and (ii) to draw a preliminary overview of the occurrence of egg and/or milk proteins in this food category. Fish and shellfish allergens were not considered in this study because they have not been the cause of food recalls to date, and because “vegan” products carrying precautionary allergen labelling (PAL) for them were not found in the market.

Materials and methods

Consumer survey

An online survey of Canadian adults with (or parents of a child with) a food allergy was conducted in 2021 as described in Graham et al. (2023) [16]. A specific question was included in this survey (but not reported in Graham et al. [16]), only for respondents that indicated having an allergy to (or being a parent of a child with an allergy to) egg or milk: When buying food products you will consume (or that will be consumed by your child with and allergy to egg or milk), how often, if ever, do you purchase products containing a vegan claim? Answer choices were: Never; Sometimes/Depends on situation; Always. Respondents could select one answer only.

Market survey

Sample collection

Food samples were randomly purchased from three different supermarkets in Quebec, Canada between March and December 2022. Items that contained the labels “vegan” or “plant-based” were targeted, regardless of their certification status. For instance, products with “vegan” on the name and products with a “certified vegan” logo somewhere on the package were classified simply as “vegan” in this study. If a “vegan” product also contained a “plant-based” claim, it was classified only as “vegan”. In some cases, the number of items sampled from the same brand was intentionally restricted, given that similar items with little modifications were found (e.g., snack bars from the same brand clearly belonging to the same product line, only with flavor variations). In this case, items with PAL for milk and/or egg, items with a longer list of ingredients, or items containing chocolate ingredients, were selected. In addition, overall, products carrying the targeted claims and also PAL for milk and/or egg were purposely selected. All types of PAL statements were considered, including but not limited to “may contain [allergen]”, “made in a facility that processes [allergen]”, “may have been in contact with [allergen]”, as well as statements including egg and/or milk along with several other allergens. In each of the retail points visited, items from all food categories (Additional file 1: Tables S1 and S2) that included the targeted labels were sampled. All samples were transported to the laboratory immediately after purchasing, stored in their original packaging, according to the instructions on the label, and analysed before their expiration dates.

Sample preparation

If products contained individually packed components (e.g., sauce and pasta), each component was analysed separately. For most samples, about half of the contents of each food product was ground using a Grindomix GM200 (Retsch, Haan, Germany). For products or their subcomponents packaged in units containing less than 20 g (e.g., sauce), the entire package content was ground. Frozen products were stored at 4 °C overnight before grinding.

ELISA methods

Food samples were analysed in duplicates using the RIDASCREEN®FAST Milk and RIDASCREEN®FAST Egg from R-Biopharm (R-Biopharm AG, Darmstadt, Germany). Results were analysed using the RIDASOFT®Win.NET software and considered positive when above the limit of quantification, corresponding to 2.5 mg/kg for milk proteins and 0.245 mg/kg for egg proteins. Samples containing components potentially subject to little or no heat treatment (e.g., low acid spreads and sauces, cookie dough, fresh pasta, not-ready-to-eat multi component foods) as well some fully cooked items (e.g., cookies, crackers, ready-to-eat meals) were tested for egg. The latter were included with the intention of detecting post-processing cross-contact egg, if present, since the kit used is recommended for the detection of raw egg proteins [17, 18]. Manufacturer instructions for sample preparation and analysis were followed for both kits. Depending on the type of food product, samples were tested for both allergens (e.g., imitation meat), for milk only (e.g., samples containing chocolate) or for egg only (e.g., imitation egg).

Results

Consumer survey

Of the total sample of 1080 questionnaires completed, 20% (211) indicated having an allergy to (or being a parent of a child with an allergy to) egg and 20% (211) to milk (further details in Graham et al. [16]). The question of interest to this study (When buying food products you will consume – or that will be consumed by your child with and allergy to egg or milk –, how often, if ever, do you purchase products containing a vegan claim?) was answered by 337 respondents as follows: Never (14%); Sometimes / Depends on situation (72%); Always (14%). Based on Clarke et al. (2019), the estimated prevalence for egg allergy is 0.8% in the Canadian population, and 1.1% for milk [19]. The estimated Canadian population is about 37 million [20]. Consequently, the sample size of survey responses provides a margin of error of 5.4% at a 95% confidence level.

Market survey

A total of 124 distinct prepackaged food samples, from 87 different brands (86% from Canada / United States, 8% from Europe and 6% from Asia), were included in this study. Most samples belonged to the “vegan” group (111/124). Among these, 18% had PAL for milk and 12% for egg (Table 1). A limited number of products marketed as “plant-based”– but not “vegan”—were found, with an 8% prevalence of PAL for milk and egg among these samples (Table 1).
Table 1
Samples included in this study and prevalence of PALa for milk and/or egg
Claimb
No. of samples
No. of samples with PAL for milk
No. of samples with PAL for egg
“Vegan”
111
20
13
“Plant-based” (but not “vegan”)
13
1
1
Total
124
21
14
aAll types of precautionary statements were considered (e.g., “may contain [allergen]”, “made in a facility that processes [allergen]”). The same product may carry PAL for milk and egg
bOn the product’s name and/or in a logo, with or without certification
Of the 124 samples collected, 87 were tested for milk proteins and 64 for egg proteins (Additional file 1: Tables S1 and S2). Egg proteins were not detected in 100% of 64 samples analysed. Milk proteins were detected in 5/87 samples analysed: 4 distinct “certified vegan” dark chocolate bars from the same manufacturer (134.9 ± 18.5 ppm) carrying PAL for milk, and 1 “vegan” supermarket brand cake—a chestnut Christmas log (2.6 ppm), listing milk in a blanket PAL statement (i.e., “may contain or may have been in contact with soy, peanuts, nuts, mustard, sesame, yeast, wheat and triticale, eggs, milk”). Considering one entire chocolate bar (0.035 kg, per product label) is likely to be consumed in one eating occasion, the mean concentration of cross-contact milk proteins detected would represent an exposure dose of 4.72 mg. This dose could elicit a reaction in approximately 6% of milk-allergic consumers [21], and is more than twice the milk reference dose (2 mg) recommended by the FAO/WHO expert consultation on food allergens [22]. The “vegan” cake’s label indicated it contained three servings. Thus, the cake’s total weight of 0.29 kg was divided by 3 to estimate the amount that would be consumed in one eating occasion (0.097 kg). The concentration of cross-contact milk proteins detected in this sample would then represent an exposure dose of 0.25 mg. This dose could elicit a reaction in approximately 1% of milk-allergic consumers [21], and is below the reference dose recommended by the FAO/WHO expert consultation [22].

Discussion

Consumer survey results indicate that 86% of respondents reporting an allergy to egg or milk would buy products with a “vegan” claim. This strongly suggests “vegan” labels may be used as indicators of safety by consumers allergic to animal proteins (i.e., milk, egg) and use them to guide purchasing decisions. This is the first time this buying behaviour is formally documented. In 2017, Marchisotto et al. [23] reported that about 40% of North American allergic consumers would buy products with PAL, while Graham et al. (2023) [16] observed that these numbers are on the rise in Canada, with 54% of allergic consumers reporting this purchasing behaviour. As the presence of PAL is directly correlated with the potential presence of an allergen hazard, it is not surprising that consumers would prefer to buy a product with a “vegan” claim—probably perceived as “absence of milk and eggs”—than one with PAL for these allergens. The number reported in this study (86% likelihood of buying “vegan” products) strongly suggests that respondents correlated the claim “vegan” with a low level of risk, potentially making it a credible indicator for allergic consumers. This is a matter of concern, as “vegan” claims should not prevail to good allergen management practices and should not be perceived as such by consumers or manufacturers. This indicates that allergic consumers are not fully aware of the food labelling regulatory framework, as previously reported [2325], and that there is a need for credible indicators directly linked to the level of cross-contact allergen risk, as suggested by the FAO/WHO expert consultation on food allergens [26]. The use of this type of indicator (e.g., a logo indicating the food manufacturer conducted an allergen risk assessment) would prevent allergic consumers from drawing conclusions based on unregulated claims like “vegan”.
Although the consumer survey focused on “vegan” labels only, products with “plant-based” (but not “vegan”) labels were also included in the market survey due to their growing market presence and the closeness of both labels’ target audiences. Furthermore, the CFIA website lists 11 recalls related to “plant-based” foods associated with undeclared ingredients (i.e., milk, egg) since 2012, 8 of which were Class 1 (i.e., based on a risk assessment, the agency considered that there was a high risk that consuming the food may lead to serious health problems or death) [27].
Market survey results indicate overall 5.7% and 0% occurrence of milk and egg proteins, respectively. Four out of 5 milk-positive samples were dark chocolate bars, containing milk proteins at relatively high levels (134.9 ± 18.5 ppm; 4.72 mg estimated exposure dose). This type of cross-contact has been previously reported and discussed [7, 2830]. Although contradictory with the general perception of a “vegan” food product, the use of PAL for milk in the chocolate bars tested in this survey is necessary to inform allergic consumers of the risk of cross-contact milk. Yet, the use of PAL along with a more visible (i.e., front label) “certified vegan” statement may mislead consumers and decrease its efficacy as a risk management tool. Milk proteins were also detected in a chestnut cake, with the text “vegan” in the product’s name (i.e., “vegan chestnut cake”) and milk in a blanket PAL statement. Although milk protein levels were lower in this sample (2.6 ppm; 0.25 mg estimated exposure dose), this finding brings up attention to the potential issue of cross-contact milk beyond dark chocolate noted in other market surveys [3, 17, 31, 32]. Yang et al. [3] included “vegan” items (n = 19) in their market survey of cross-contact milk in milk-alternative frozen desserts; all these samples were below the level of quantification, as was the case for all items of this food category (n = 5) included in our survey. In addition, although applicable to a different jurisdiction (United States), Yang et al. (2022) [3] also raised the issue of potentially contradictory labelling (e.g., “vegan” items with PAL for milk) and the risk it may pose to consumers seeking to avoid milk. No other market surveys of cross-contact allergens in “vegan” products were found in the literature. Although not as often as milk, undeclared egg has also been previously reported [17, 18, 31], but mostly in cooked items (e.g., baked goods, snacks, fishery items), with no mention of “vegan” labels. Thus, our results are not comparable. Future studies could investigate the occurrence of cross-contact egg in thermally treated “vegan” or “plant-based” items, and thus expand our survey, which targeted detection of egg in food products subject to little or no heat treatment. This however would require the selection of a fit for purpose analytical method, given that the test kit used in our study (RIDASCREEN®FAST Egg) is not indicated for this purpose and may therefore result in underestimation [18].
Overall, the results of this market survey indicate that, in Quebec, prepackaged foods carrying “vegan” or “plant-based” labels pose little risk to egg- or milk-allergic consumers. However, given the high prevalence of Canadian brands among the products surveyed (51/84), this is most likely due to allergen management practices applied by this industry [33], and should not be attributed to the use of “vegan” or similar labels. These claims are not regulated with respect to the content of ingredients of animal origin and must not be interpreted as such by consumers allergic to animal proteins. It is possible that the high prevalence (more than 80%) of egg- and milk-allergic individuals choosing to consume “vegan” foods is due to a lack of awareness of regulatory requirements associated with this claim coupled with absence or very low levels of cross-contact egg and milk proteins in most of these items, reinforcing their misperception of guaranteed safety. This behaviour may be compared to previous reports [28, 34] of allergic individuals consuming products with PAL because they did not experience an allergic reaction after testing a small portion, and incorrectly assuming these products will consistently deliver the same level of safety. Thus, a consumer education campaign on the regulatory meaning of “vegan” and similar labels, highlighting the potential presence of cross-contact allergens, and therefore PAL, may be warranted, especially considering that not all food manufacturers adhere to allergen management practices equivalent to those applied in Canada. On the other hand, manufacturers should be aware of how some allergic consumers interpret “vegan” claims (e.g., absence of ingredients of animal origin) and avoid specifically targeting this population (e.g., avoid using statements like “allergy friendly”—as noted in one item in this survey). The working definition of “vegan” provided by CFIA indicates that criteria other than the food’s ingredients may be considered when using this claim [4]. Consequently, the presence of ingredients of animal origin or the use of PAL for these is beyond the scope of regulatory enforcement. Adherence to a “vegan” diet usually reflects a consumer’s ideological concerns and is not normally intended to prevent acute health issues such as food allergies. However, the fact that some allergic consumers may use “vegan” claims as indicators of a product’s safety should concern regulatory authorities. For example, in some cases, this claim may be seen as an alternative to “dairy-free” by manufacturers and/or consumers, but the risk to milk-allergic consumers is not comparable.
Limitations of this market survey include a potential underestimation of egg proteins in baked items, considering that the kit used is better suited for the detection of raw egg proteins. In addition, the market survey’s scope is geographically limited (only foods sold in Quebec, Canada). Nevertheless, it provides an overview of the occurrence of two of the main allergens of animal origin (i.e., egg and milk) in most food groups carrying “vegan” or “plant-based” labels. These results however must not be extrapolated to foods sold in bulk with similar claims, which may present a different level of risk [35].

Conclusions

Egg- or milk-allergic consumers include “vegan” products in their buying choices, suggesting they perceive them as safe. The products analysed in this study posed little or no risk to consumers allergic to egg or milk proteins. This however should not be attributed to “vegan” or “plant-based” claims, which are not regulated in Canada to indicate the absence of the relevant offending allergen and are not intended to communicate risks to consumers. Instead, our analytical results may be reflective of allergen management practices applied by Canadian food manufacturers in general. Efforts should be considered to enhance specific regulatory requirements for the use of “vegan” and similar claims, including provisions related to the implementation of appropriate allergen control plans. Finally, an education campaign on the meaning of “vegan” and similar claims with respect to allergenic risk is necessary to better inform this population’s food purchasing strategies.

Acknowledgements

The authors would like to thank Dr. Sébastien La Vieille, member of the Food Risk Analysis and Regulatory Excellence Platform (PARERA) at Université Laval, for critically reviewing the manuscript before its initial submission; and Janet Halliday, Principal, Strategic Navigator Inc., and Jennifer Bermingham, Principal, Strategic Navigator Inc., for designing and executing the consumer survey.

Declarations

Ethics approval was obtained from the Hamilton Integrated Research Ethics Board of McMaster University (Project Number 13589).
Not applicable.

Competing interests

SBG’s research activities are funded by the Ministry of Agriculture, Fisheries, and Food, Government of Quebec, Canada; the Ministry of Science, Technology, and Innovation, Government of Quebec; Canada's Innovation Foundation; the U.S. Department of Agriculture Foreign Agriculture Service; R-Biopharm GmbH; and R-Biopharm Canada Inc. SBG acts as an expert advisor for members of the food and beverage industry, international organizations (the Food and Agriculture Organization of the United Nations, the United Nations Industrial Development Organization, and the World Bank), and international food regulators such as the China National Centre for Food Safety Risk Assessment and consumer organizations such as Food Allergy Canada. JG and BP are employees of Food Allergy Canada. Food Allergy Canada receives unrestricted grants supporting educational programming from Pfizer and Bausch Health. The other authors declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
2.
Zurück zum Zitat Aschemann-Witzel J, Gantriis RF, Fraga P, Perez-Cueto FJA. Plant-based food and protein trend from a business perspective: markets, consumers, and the challenges and opportunities in the future. Crit Rev Food Sci Nutr. 2021;61:3119–28.CrossRefPubMed Aschemann-Witzel J, Gantriis RF, Fraga P, Perez-Cueto FJA. Plant-based food and protein trend from a business perspective: markets, consumers, and the challenges and opportunities in the future. Crit Rev Food Sci Nutr. 2021;61:3119–28.CrossRefPubMed
3.
Zurück zum Zitat Yang LGL, Brewster RK, Donnell MT, Hirani RN. Risk characterisation of milk protein contamination in milk-alternative ice cream products sold as frozen desserts in the United States. Food Addit Contam Part A. 2022;39:1–13.CrossRef Yang LGL, Brewster RK, Donnell MT, Hirani RN. Risk characterisation of milk protein contamination in milk-alternative ice cream products sold as frozen desserts in the United States. Food Addit Contam Part A. 2022;39:1–13.CrossRef
7.
Zurück zum Zitat Bedford B, Yu Y, Wang X, Garber EAE, Jackson LS. A limited survey of dark chocolate bars obtained in the United States for undeclared milk and peanut allergens. J Food Prot. 2017;80:692–702.CrossRefPubMed Bedford B, Yu Y, Wang X, Garber EAE, Jackson LS. A limited survey of dark chocolate bars obtained in the United States for undeclared milk and peanut allergens. J Food Prot. 2017;80:692–702.CrossRefPubMed
8.
Zurück zum Zitat Martínez-Pineda M, Yagüe-Ruiz C. The risk of undeclared allergens on food labels for pediatric patients in the European Union. Nutrients. 2022;14:1571.CrossRefPubMedPubMedCentral Martínez-Pineda M, Yagüe-Ruiz C. The risk of undeclared allergens on food labels for pediatric patients in the European Union. Nutrients. 2022;14:1571.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Soller L, La Vieille S, Cameron SB, Mak R, Cook VE, Gerdts J, Chan ES. Allergic reactions to emerging food allergens in Canadian children. Allergy Asthma Clin Immunol. 2021;17:71.CrossRefPubMedPubMedCentral Soller L, La Vieille S, Cameron SB, Mak R, Cook VE, Gerdts J, Chan ES. Allergic reactions to emerging food allergens in Canadian children. Allergy Asthma Clin Immunol. 2021;17:71.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Cosyns JCE, Frykas TLM, Hildebrand HV, Kim H, Gerdts JD, Abrams EM, Protudjer JLP. Peanut, soy, and emerging legume allergy in Canada. J Allergy Clin Immunol Global. 2022;1:319–21.CrossRef Cosyns JCE, Frykas TLM, Hildebrand HV, Kim H, Gerdts JD, Abrams EM, Protudjer JLP. Peanut, soy, and emerging legume allergy in Canada. J Allergy Clin Immunol Global. 2022;1:319–21.CrossRef
16.
Zurück zum Zitat Graham F, Waserman S, Gerdts J, Povolo B, La Vieille S. Perceptions of allergic consumers and allergists on precautionary allergen labelling: where do we go from here? Allergy Asthma Clin Immunol. 2023;8:1428. Graham F, Waserman S, Gerdts J, Povolo B, La Vieille S. Perceptions of allergic consumers and allergists on precautionary allergen labelling: where do we go from here? Allergy Asthma Clin Immunol. 2023;8:1428.
17.
Zurück zum Zitat Manny E, La Vieille S, Barrere V, Theolier J, Godefroy SB. Occurrence of milk and egg allergens in foodstuffs in Canada. Food Addit Contam Part A. 2021;38:15–32.CrossRef Manny E, La Vieille S, Barrere V, Theolier J, Godefroy SB. Occurrence of milk and egg allergens in foodstuffs in Canada. Food Addit Contam Part A. 2021;38:15–32.CrossRef
18.
Zurück zum Zitat Khuda SE, Sharma GM, Gaines D, Do AB, Pereira M, Chang M, Ferguson M, Williams KM. Survey of undeclared egg allergen levels in the most frequently recalled food types (including products bearing precautionary labelling). Food Addit Contam Part A. 2016;33:1265–73. Khuda SE, Sharma GM, Gaines D, Do AB, Pereira M, Chang M, Ferguson M, Williams KM. Survey of undeclared egg allergen levels in the most frequently recalled food types (including products bearing precautionary labelling). Food Addit Contam Part A. 2016;33:1265–73.
19.
Zurück zum Zitat Clarke AE, Elliott SJ, St. Pierre Y, Soller L, La Vieille S, Ben-Shoshan M. Temporal trends in prevalence of food allergy in Canada. J Allergy Clin Immunol Pract. 2020;8:1428–30.CrossRefPubMed Clarke AE, Elliott SJ, St. Pierre Y, Soller L, La Vieille S, Ben-Shoshan M. Temporal trends in prevalence of food allergy in Canada. J Allergy Clin Immunol Pract. 2020;8:1428–30.CrossRefPubMed
21.
Zurück zum Zitat Houben GF, Baumert JL, Blom WM, Kruizinga AG, Meima MY, Remington BC, Wheeler MW, Westerhout J, Taylor SL. Full range of population Eliciting Dose values for 14 priority allergenic foods and recommendations for use in risk characterization. Food Chem Toxicol. 2020;146:111831.CrossRefPubMedPubMedCentral Houben GF, Baumert JL, Blom WM, Kruizinga AG, Meima MY, Remington BC, Wheeler MW, Westerhout J, Taylor SL. Full range of population Eliciting Dose values for 14 priority allergenic foods and recommendations for use in risk characterization. Food Chem Toxicol. 2020;146:111831.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Marchisotto MJ, Harada L, Kamdar O, Smith BM, Waserman S, Sicherer S, Allen K, Muraro A, Taylor S, Gupta RS. Food allergen labeling and purchasing habits in the United States and Canada. J Allergy Clin Immunol Pract. 2017;5:345-51.e2.CrossRefPubMed Marchisotto MJ, Harada L, Kamdar O, Smith BM, Waserman S, Sicherer S, Allen K, Muraro A, Taylor S, Gupta RS. Food allergen labeling and purchasing habits in the United States and Canada. J Allergy Clin Immunol Pract. 2017;5:345-51.e2.CrossRefPubMed
24.
Zurück zum Zitat Holleman BC, van Os-Medendorp H, van den Bergh H, van Dijk LM, Linders YFM, Blom MW, Verhoeckx KCM, Michelsen-Huisman A, Houben GH, Knulst AC, Lentz LR. Poor understanding of allergen labelling by allergic and non- allergic consumers. Clin Exp Allergy. 2021;51:1374–82.CrossRefPubMedPubMedCentral Holleman BC, van Os-Medendorp H, van den Bergh H, van Dijk LM, Linders YFM, Blom MW, Verhoeckx KCM, Michelsen-Huisman A, Houben GH, Knulst AC, Lentz LR. Poor understanding of allergen labelling by allergic and non- allergic consumers. Clin Exp Allergy. 2021;51:1374–82.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat DunnGalvin A, Chan C-H, Crevel R, Grimshaw K, Poms R, Schnadt S, et al. Precautionary allergen labelling: perspectives from key stakeholder groups. Allergy. 2015;70:1039–51.CrossRefPubMed DunnGalvin A, Chan C-H, Crevel R, Grimshaw K, Poms R, Schnadt S, et al. Precautionary allergen labelling: perspectives from key stakeholder groups. Allergy. 2015;70:1039–51.CrossRefPubMed
28.
Zurück zum Zitat Manny E, La Vieille S, Dominguez SA, Kos G, Barrère V, Théolier J, Touma J, Godefroy SB. Probabilistic risk assessment for milk in dark chocolate, cookies and other baked goods with PAL sold in Canada. Food Chem Toxicol. 2021;152:112196.CrossRefPubMed Manny E, La Vieille S, Dominguez SA, Kos G, Barrère V, Théolier J, Touma J, Godefroy SB. Probabilistic risk assessment for milk in dark chocolate, cookies and other baked goods with PAL sold in Canada. Food Chem Toxicol. 2021;152:112196.CrossRefPubMed
30.
Zurück zum Zitat Spanjersberg MQI, Knulst AC, Kruizinga AG, van Duijn G, Houben GF. Concentrations of undeclared allergens in food products can reach levels that are relevant for public health. Food Addit Contam Part A. 2010;27:169–74.CrossRef Spanjersberg MQI, Knulst AC, Kruizinga AG, van Duijn G, Houben GF. Concentrations of undeclared allergens in food products can reach levels that are relevant for public health. Food Addit Contam Part A. 2010;27:169–74.CrossRef
31.
Zurück zum Zitat Surojanametakul V, Khaiprapai P, Jithan P, Varanyanond W, Sholi M, Ito T, Tamura H. Investigation of undeclared food allergens in commercial Thai food products. Food Control. 2012;23:1–6.CrossRef Surojanametakul V, Khaiprapai P, Jithan P, Varanyanond W, Sholi M, Ito T, Tamura H. Investigation of undeclared food allergens in commercial Thai food products. Food Control. 2012;23:1–6.CrossRef
32.
Zurück zum Zitat Bianco M, Calvano CD, Ventura G, Losito I, Cataldi TRI. Determination of hidden milk allergens in meat-based foodstuffs by liquid chromatography coupled to electrospray ionization and high-resolution tandem mass spectrometry. Food Control. 2022;131:108443.CrossRef Bianco M, Calvano CD, Ventura G, Losito I, Cataldi TRI. Determination of hidden milk allergens in meat-based foodstuffs by liquid chromatography coupled to electrospray ionization and high-resolution tandem mass spectrometry. Food Control. 2022;131:108443.CrossRef
33.
Zurück zum Zitat Dominguez S, Théolier J, Povolo B, Gerdts J, Godefroy SB. Allergen management under a voluntary PAL regulatory framework—a survey of Canadian food processors. Heliyon. 2022;8:11302.CrossRef Dominguez S, Théolier J, Povolo B, Gerdts J, Godefroy SB. Allergen management under a voluntary PAL regulatory framework—a survey of Canadian food processors. Heliyon. 2022;8:11302.CrossRef
34.
Zurück zum Zitat Monks H, Gowland MH, MacKenzie H, Erlewyn-Lajeunesse M, King R, Lucas JS, Roberts G. How do teenagers manage their food allergies? Clin Exp Allergy. 2010;40:1533–40.CrossRefPubMed Monks H, Gowland MH, MacKenzie H, Erlewyn-Lajeunesse M, King R, Lucas JS, Roberts G. How do teenagers manage their food allergies? Clin Exp Allergy. 2010;40:1533–40.CrossRefPubMed
35.
Zurück zum Zitat Trendelenburg V, Enzian N, Bellach J, Schnadt S, Niggemann B, Beyer K. Detection of relevant amounts of cow’s milk protein in non-pre-packed bakery products sold as cow’s milk-free. Allergy Eur J Allergy Clin Immunol. 2015;70:591–7.CrossRef Trendelenburg V, Enzian N, Bellach J, Schnadt S, Niggemann B, Beyer K. Detection of relevant amounts of cow’s milk protein in non-pre-packed bakery products sold as cow’s milk-free. Allergy Eur J Allergy Clin Immunol. 2015;70:591–7.CrossRef
Metadaten
Titel
“Vegan” and “plant-based” claims: risk implications for milk- and egg-allergic consumers in Canada
verfasst von
Silvia Dominguez
Jérémie Théolier
Kamila Lizée
Beatrice Povolo
Jennifer Gerdts
Samuel B. Godefroy
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
Allergy, Asthma & Clinical Immunology / Ausgabe 1/2023
Elektronische ISSN: 1710-1492
DOI
https://doi.org/10.1186/s13223-023-00836-w

Weitere Artikel der Ausgabe 1/2023

Allergy, Asthma & Clinical Immunology 1/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.